Search ( Ctrl + / )
Vertex Pharmaceuticals
VRTXNASDAQ
VRTXNASDAQ
VRTXNASDAQ
| Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | |
|---|---|---|---|---|---|---|---|---|
| Statement Date | 12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
| Cash and Cash Equivalents | 2024 | 2024 | 2024 | 2024 | 2023 | 2023 | 2023 | 2023 |
| Short Term Investments | 1.55B | 1.29B | 1.22B | 1.01B | 849.20M | 11.93B | 11.24B | 1.12B |
| Cash and Short Term Investments | 6.12B | 6.52B | 5.80B | 10.17B | 11.22B | 11.93B | 11.24B | 10.41B |
| Net Receivables | 1.61B | 1.75B | 1.66B | 1.79B | 1.56B | 1.54B | 1.56B | 1.55B |
| Inventory | 1.21B | 1.08B | 914.60M | 813.10M | 738.80M | 688.70M | 603.50M | 535.10M |
| Other Current Assets | 665.70M | 449.20M | 575.40M | 511.10M | 620.50M | 540.20M | 476.90M | 468.70M |
| Total Current Assets | 9.60B | 9.80B | 8.94B | 13.29B | 14.14B | 14.70B | 13.87B | 12.97B |
| Property Plant Equipment Net | 2.58B | 2.51B | 1.77B | 1.49B | 1.45B | 1.43B | 1.45B | 1.45B |
| Goodwill | 1.09B | 1.09B | 1.09B | 1.09B | 1.09B | 1.09B | 1.09B | 1.09B |
| Intangible Assets | 825.90M | 831.60M | 837.50M | 834.90M | 839.90M | 603.60M | 603.60M | 603.60M |
| Goodwill and Intangible Assets | 1.91B | 1.92B | 1.93B | 1.92B | 1.93B | 1.69B | 1.69B | 1.69B |
| Long Term Investments | 5.11B | 4.70B | 4.40B | 4.46B | 2.60B | 1.70B | 1.36B | 1.08B |
| Tax Assets | 2.33B | 2.31B | 2.19B | 1.96B | 1.81B | 1.73B | 1.54B | 1.36B |
| Other Non Current Assets | 999.30M | 990.20M | 910.80M | 801.40M | 796.70M | 475.20M | 442.70M | 427.50M |
| Total Non Current Assets | 12.94B | 12.44B | 11.19B | 10.63B | 8.59B | 7.03B | 6.48B | 6.01B |
| Other Assets | 0.00 | 0.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Assets | 22.53B | 22.24B | 20.13B | 23.92B | 22.73B | 21.73B | 20.35B | 18.97B |
| Account Payables | 413.00M | 395.80M | 327.90M | 351.40M | 364.90M | 375.90M | 363.00M | 323.20M |
| Short Term Debt | 92.30M | 0.00 | 0.00 | 0.00 | 83.70M | 0.00 | 0.00 | 0.00 |
| Tax Payables | 161.10M | 0.00 | 0.00 | 0.00 | 99.50M | 0.00 | 0.00 | 0.00 |
| Deferred Revenue | 206.80M | 0.00 | 128.30M | 275.80M | 170.30M | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 2.69B | 3.58B | 3.22B | 3.44B | 2.93B | 3.22B | 2.99B | 2.70B |
| Total Current Liabilities | 3.56B | 3.97B | 3.55B | 3.80B | 3.55B | 3.60B | 3.35B | 3.03B |
| Long Term Debt | 1.66B | 1.70B | 1.87B | 1.44B | 724.70M | 744.70M | 767.60M | 789.20M |
| Deferred Revenue Non Current | 0.00 | 0.00 | 0.00 | 0.00 | -924.10M | 0.00 | 0.00 | 0.00 |
| Deferred Tax Liabilities Non Current | 0.00 | 0.00 | 0.00 | 0.00 | 924.10M | 0.00 | 0.00 | 0.00 |
| Other Non Current Liabilities | 901.80M | 933.30M | -56.60M | 132.30M | 877.70M | 869.30M | 759.30M | 726.50M |
| Total Non Current Liabilities | 2.56B | 2.64B | 1.81B | 1.57B | 1.60B | 1.61B | 1.53B | 1.52B |
| Other Liabilities | 0.00 | 0.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 6.12B | 6.61B | 5.36B | 5.37B | 5.15B | 5.21B | 4.88B | 4.54B |
| Common Stock | 2.60M | 2.60M | 2.60M | 2.60M | 2.60M | 257.80M | 257.80M | 2.60M |
| Retained Earnings | 9.61B | 8.69B | 7.65B | 11.24B | 10.14B | 9.17B | 8.14B | 7.22B |
| Accumulated Other Comprehensive Income Loss | 127.80M | 28.80M | 22.50M | 17.30M | -14.30M | -3.00M | -39.80M | -13.10M |
| Other Total Stockholders Equity | 6.67B | 6.91B | 7.10B | 7.28B | 7.45B | 7.08B | 7.11B | 7.22B |
| Total Stockholders Equity | 16.41B | 15.63B | 14.77B | 18.55B | 17.58B | 16.51B | 15.47B | 14.43B |
| Total Liabilities and Stockholders Equity | 22.53B | 22.24B | 20.13B | 23.92B | 22.73B | 21.73B | 20.35B | 18.97B |
| Total Investments | 6.65B | 5.99B | 5.61B | 5.47B | 3.45B | 13.63B | 12.59B | 2.21B |
| Total Debt | 1.75B | 1.70B | 933.40M | 721.30M | 808.40M | 744.70M | 767.60M | 789.20M |
| Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | |
|---|---|---|---|---|---|---|---|---|
| Statement Date | 12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
| Cash and Cash Equivalents | 2024 | 2024 | 2024 | 2024 | 2023 | 2023 | 2023 | 2023 |
| Short Term Investments | 1.55B | 1.29B | 1.22B | 1.01B | 849.20M | 11.93B | 11.24B | 1.12B |
| Cash and Short Term Investments | 6.12B | 6.52B | 5.80B | 10.17B | 11.22B | 11.93B | 11.24B | 10.41B |
| Net Receivables | 1.61B | 1.75B | 1.66B | 1.79B | 1.56B | 1.54B | 1.56B | 1.55B |
| Inventory | 1.21B | 1.08B | 914.60M | 813.10M | 738.80M | 688.70M | 603.50M | 535.10M |
| Other Current Assets | 665.70M | 449.20M | 575.40M | 511.10M | 620.50M | 540.20M | 476.90M | 468.70M |
| Total Current Assets | 9.60B | 9.80B | 8.94B | 13.29B | 14.14B | 14.70B | 13.87B | 12.97B |
| Property Plant Equipment Net | 2.58B | 2.51B | 1.77B | 1.49B | 1.45B | 1.43B | 1.45B | 1.45B |
| Goodwill | 1.09B | 1.09B | 1.09B | 1.09B | 1.09B | 1.09B | 1.09B | 1.09B |
| Intangible Assets | 825.90M | 831.60M | 837.50M | 834.90M | 839.90M | 603.60M | 603.60M | 603.60M |
| Goodwill and Intangible Assets | 1.91B | 1.92B | 1.93B | 1.92B | 1.93B | 1.69B | 1.69B | 1.69B |
| Long Term Investments | 5.11B | 4.70B | 4.40B | 4.46B | 2.60B | 1.70B | 1.36B | 1.08B |
| Tax Assets | 2.33B | 2.31B | 2.19B | 1.96B | 1.81B | 1.73B | 1.54B | 1.36B |
| Other Non Current Assets | 999.30M | 990.20M | 910.80M | 801.40M | 796.70M | 475.20M | 442.70M | 427.50M |
| Total Non Current Assets | 12.94B | 12.44B | 11.19B | 10.63B | 8.59B | 7.03B | 6.48B | 6.01B |
| Other Assets | 0.00 | 0.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Assets | 22.53B | 22.24B | 20.13B | 23.92B | 22.73B | 21.73B | 20.35B | 18.97B |
| Account Payables | 413.00M | 395.80M | 327.90M | 351.40M | 364.90M | 375.90M | 363.00M | 323.20M |
| Short Term Debt | 92.30M | 0.00 | 0.00 | 0.00 | 83.70M | 0.00 | 0.00 | 0.00 |
| Tax Payables | 161.10M | 0.00 | 0.00 | 0.00 | 99.50M | 0.00 | 0.00 | 0.00 |
| Deferred Revenue | 206.80M | 0.00 | 128.30M | 275.80M | 170.30M | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 2.69B | 3.58B | 3.22B | 3.44B | 2.93B | 3.22B | 2.99B | 2.70B |
| Total Current Liabilities | 3.56B | 3.97B | 3.55B | 3.80B | 3.55B | 3.60B | 3.35B | 3.03B |
| Long Term Debt | 1.66B | 1.70B | 1.87B | 1.44B | 724.70M | 744.70M | 767.60M | 789.20M |
| Deferred Revenue Non Current | 0.00 | 0.00 | 0.00 | 0.00 | -924.10M | 0.00 | 0.00 | 0.00 |
| Deferred Tax Liabilities Non Current | 0.00 | 0.00 | 0.00 | 0.00 | 924.10M | 0.00 | 0.00 | 0.00 |
| Other Non Current Liabilities | 901.80M | 933.30M | -56.60M | 132.30M | 877.70M | 869.30M | 759.30M | 726.50M |
| Total Non Current Liabilities | 2.56B | 2.64B | 1.81B | 1.57B | 1.60B | 1.61B | 1.53B | 1.52B |
| Other Liabilities | 0.00 | 0.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 6.12B | 6.61B | 5.36B | 5.37B | 5.15B | 5.21B | 4.88B | 4.54B |
| Common Stock | 2.60M | 2.60M | 2.60M | 2.60M | 2.60M | 257.80M | 257.80M | 2.60M |
| Retained Earnings | 9.61B | 8.69B | 7.65B | 11.24B | 10.14B | 9.17B | 8.14B | 7.22B |
| Accumulated Other Comprehensive Income Loss | 127.80M | 28.80M | 22.50M | 17.30M | -14.30M | -3.00M | -39.80M | -13.10M |
| Other Total Stockholders Equity | 6.67B | 6.91B | 7.10B | 7.28B | 7.45B | 7.08B | 7.11B | 7.22B |
| Total Stockholders Equity | 16.41B | 15.63B | 14.77B | 18.55B | 17.58B | 16.51B | 15.47B | 14.43B |
| Total Liabilities and Stockholders Equity | 22.53B | 22.24B | 20.13B | 23.92B | 22.73B | 21.73B | 20.35B | 18.97B |
| Total Investments | 6.65B | 5.99B | 5.61B | 5.47B | 3.45B | 13.63B | 12.59B | 2.21B |
| Total Debt | 1.75B | 1.70B | 933.40M | 721.30M | 808.40M | 744.70M | 767.60M | 789.20M |